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In the present article we describe the spectroscopic data of 1H and 13C
Nuclear Magnetic Resonance of 11 compounds including: Nine natural
products from the hexanic-chloroformic and methanolic extracts of
Acacia farnesiana fruit and two esterified derivatives (22E-stimasta-
5,22-dien- 3β-acetyl and methyl 3,4,5-triacetyloxybenzoate). Data
linked to the research work entitled "Chemical composition of fruits of
Acacia farnesiana (L) Willd and its activity against Mycobacterium
tuberculosis and dysentery bacteria" (Hernández et al., 2019) [1].
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elated research article Hernández, E., Garza, E., García, A., Avalos, F.G., Rivas, V. M., Rodríguez,
J., Alcántar, V. M., Delgadillo, C., Camacho M. R. Chemical composition
of Acacia farnesiana (L) wild fruits and its activity against Myco-
bacterium tuberculosis and dysentery bacteria. J. Ethnopharmacol 2019
230: 74–80 [1].Value of the data
 The spectroscopic characterization of natural products reported in this article is important in the
metabolic chemical characterization processes of plants of the same family, genus or different plant
species.
 It is possible the chracterization of new o related phytochemicals by comparision with the provided
spectroscopic data.1. Data
1H and 13C Nuclear Magnetic Resonance techniques allowed the characterization of isolated
compounds from the hexanic, chloroformic and methanolic extracts of Acacia farnesiana and ester-
ified derivatives. NMR spectra data is shown, as well as the detailed description of the spectroscopic
signals (chemical shift, integration, coupling constants, multiplicity and signal assignment), see
Figs. 1–22 with this article.2. Experimental design, materials and methods
One-dimensional nuclear magnetic resonance (NMR) spectra were obtained using the Bruker
AVANCE III HD 400MHz equipment. Deuterated solvents (CDCl3, DMSO-d6, acetone-d6 and D2O) were
used based on the dissolution needs of the compounds to be studied and tetramethylsilane (TMS) as
internal standard.
5–10mg of each compound analyzed was weighed in analytical balance and 0.5mL of deuterated
solvent was added to sample until complete solubility. Then solution was placed in a clean and dry
resonance tube.
To obtain the spectroscopic data of hydrogen nucleus (1H), a 400MHz equipment frequency was
used, while for the carbon nucleus (13C) a frequency of 100MHz was used.
Fig. 1. 22E-stimasta-5,22-dien-3β-ol, NMR 1H (400MHz CDCl3) δ ppm: 0.69 (s, 3H, Me-18), 0.79 (d, J¼6.92Hz, 3H, Me-27), 0.80
(t, J¼7.1Hz, 3H, Me-29), 0.83 (d, J¼7.32Hz, 3H, Me-26), 0.86 (d, J¼3.8Hz, 2H, H-28), 0.92 (d, J¼6.4Hz, 2H, H-9, H-24), 1.01 (s, 3H,
Me-19), 1.02 (d, J¼7. 72Hz, 3H, Me-21), 1.10 (m,1H, H-14), 1.04 (m, 2H, H-1), 1.07 (m, 2H, H-15), 1.11 (m, 1H, H-14),1.13 (m, 1H, H-17),
1.16 (m, 1H, H-12), 1.28 (m, 1H, H-16), 1.41 (m, 1H, H-20), 1.53 (m, 2H, H-7), 1.54 (m, 1H, H-11), 1.83 (m, 1H, H-25), 1.84 (m, 2H, H-2),
1.85 (m, 1H, H-16), 1.99 (m, 1H, H-8), 2.0 (m, 2H, H-12), 2.28 (m, 2H, H-4), 3.52 (m, 1H, H-3), 5.01 (dd, J¼15.1, 8.6Hz, 1H, H-23), 5.15
(dd, J¼15.1, 8.5Hz, 1H, H-22), 5.35 (brd, J¼4.72Hz, 1H, H-6).
Fig. 2. 22E-stimasta-5,22-dien-3β-ol, NMR 13C (100MHz, CDCl3) δ ppm: 12.05 (C18), 12.25 (C29), 19.03 (C27), 19.40 (C19), 21.08
(C11, C26), 21.21 (C21), 24.36 (C15), 25.41 (C28), 28.92 (C16), 31.67 (C2), 31.88 (C7, C8), 31.90 (C25), 36.51 (C10), 37.26 (C1), 39.78
(C12), 40.49 (C20), 42.22 (C13), 42.31 (C4), 50.14 (C9), 51.24 (C24), 55.96 (C17), 56.87 (C14), 71.81 (C3), 121.71 (C6), 129.28 (C23),
138.32 (C22), 140.76 (C5).
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Fig. 3. 22E-stimasta-5,22-dien-3β-acetyl, NMR 1H (400MHz, CDCl3) δ ppm: 0.69 (s, 3H, Me-18), 0.79 (d, J¼6.96Hz, 3H, Me-27) 0.80
(t, J¼7.04Hz, 3H, Me-29), 0.82 (d, J¼1.74Hz, 2H, H-28), 0.83 (d, J¼7.2Hz, 3H, Me-26),), 0.91 (m, 1H, H-24) 0.92 (d, J¼6.54Hz, 1H, H-9),
1.02 (s, 3H, Me-19), 1.021 (d, J¼6.36Hz, 3H, Me-21), 1.12 (m, 1H, H-14), 1.13 (m, 2H, H-15), 1.16 (m, 2H, H-1), 1.17 (m, 1H, H-17), 1.18
(m, 1H, H-12), 1.28 (m, 1H, H-16), 1.42 (m, 1H, H-20), 1.53 (m, 2H, H-11), 1.54 (m, 2H, H-7), 1.83 (m, 1H, H-25), 1.84 (m, 2H, H-2), 1.87
(m, 1H, H-16), 1.98 (m, 1H, H-8), 1.99 (m, 2H, H-12), 2.03 (s, 3H, CH3CO), 2.32 (m, 2H, H-4), 4.6 (m, 1H, H-3), 5.01 (dd, J¼15.16, 8.64Hz,
1H, H-23), 5.15 (dd, J¼15.16, 8.6Hz, 1H, H-22), 5.37 (brd, J¼4.64, 1H, H-6).
Fig. 4. 22E-stimasta-5,22-dien-3β-acetyl. NMR 13C (100MHz, CDCl3) δ ppm: 12.04 (C18), 12.24(C29), 18.98 (C27), 19.30 (C19),
21.01 (C11), 21.08 (C26), 21.21 (C21), 21.44 (CH3CO), 24.35 (C15), 25.40 (C28), 27.77 (C2), 28.90 (C16), 31.86 (C7, C8), 31.88 (C25),
36.59 (C10), 36.99 (C1), 38.12 (C4), 39.62 (C12), 40.49 (C20), 42.20 (C13), 50.05 (C9), 51.23 (C24), 55.93 (C17), 56.78 (C14), 74.0
(C3), 122.63 (C6), 129.28 (C23), 138.31 (C22), 139.65 (C5), 170.56 (CH3CO).
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Fig. 5. Tetracosanoic acid (2S)-2, 3-dihydroxypropyl ester, NMR 1H (400MHz, CDCl3) δ ppm: 0.88 (t, J¼6.78 Hz, 3H, Me-24),
1.25 (sa, 38H, (CH2)19, C4-C22), 1.50 (sa, 1H, OH-3´), 1.63 (m, 4H, H-3, H-23), 2.04 (s, 1H, OH-2´), 2.35 (t, J¼7.58 Hz, 2H, H-2), 3.60
(dd, J¼11.46, 5.78 Hz, 1H, H-3´β), 3.70 (dd, J¼11.46, 3.98 Hz, 1H, H-3´α), 3.94 (m, 1H, H-2´), 4.15 (dd, J¼11.68, 6.12 Hz, 1H, H-1´β),
4.21 (dd, J¼11.64, 4.6 Hz, 1H, H-1´α).
Fig. 6. Tetracosanoic acid (2S)-2, 3-dihydroxypropyl ester, NMR 13C (100MHz, CDCl3) δ ppm: 14.35 (C24), 22.91 (C23), 25.13
(C3), 29.34 (C4), 29.46 (C5), 29.58 (C8), 29.67 (C9), 29.82 (C21), 29.86 (C6), 29.88 (C7), 29.92 (C10-C20), 32.14 (C22), 34.37 (C2),
63.53 (C3´), 65.38 (C1´), 70.48 (C2´), 174.61 (C1).
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Fig. 7. Stigmasta-5,22-dien-3β-O-D-glucopyranoside, NMR 1H (400MHz, DMSO-d6) δ ppm: 0.64 (s, 3H, Me-18), 0.79 (t, J¼ 7.40Hz,
3H, Me-29), 0.80 (d, J¼ 7.64Hz, 3H, Me-27), 0.81 (m, 1H, H-9), 0.83 (m, 1H, H-24), 0.89 (d, J¼ 6.24Hz, 3H, Me-26), 0.95
(s, 3H, Me-19), 0.99 (d, J¼ 6.36Hz, 3H, Me-21), 1.03 (m, 1H, H-17), 1.07 (m, 2H, H-15), 1.09 (m, 1H, H-9), 1.14 (m, 2H, H-12), 1.19
(d, J¼ 7.1Hz, 1H, H-4), 1.22 (m, 2H, H-11), 1.37 (m, 2H, H-2), 1.40 (m, 1H, H-20), 1.46 (m, 1H, H-25), 1.49 (m, 2H, H-7), 1.62 (dd, J¼ 6.4,
11.6, 1H, H-8), 1.78 (m, 1H, H-16), 1.80 (m, 1H, H-4), 1.93 (m, 1H, H-16), 2.11 (m, 1H, H-1), 2.36 (dd, J¼ 3.0, 13.3Hz, 1H, H-1), 2.88
(m, 1H, H-2´), 3.01 (m, 2H, H-5´), 3.04 (m, 2H, 4´), 3.11 (m, 1H, H-3´), 3.46 (m, 1H, H-3), 3.48 (m, 1H, H-6´a), 3.63 (dd, J¼ 10.7, 5.4 Hz,
1H, H-6´b), 4.21 (d, J¼ 7.72Hz, 1H, H-1´), 4.45 (t, J¼ 5.6Hz, 1H, OH-6´), 4.88 (sa, 1H, OH-4´), 4.89 (sa, 1H, OH-2´), 4.91 (d, J ¼ 4.5Hz,
1H, OH-3´), 5.01 (dd, J¼ 15, 8.72, Hz, 1H, H-23), 5.15 (dd, J¼ 15.04, 8.62Hz, 1H, H-22), 5.32 (sa, 1H, H-6).
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Fig. 9. Stigmasta-5,22-dien-3β-O-D-tetraacetylglucopyranoside, NMR 1H (400MHz, CDCl3) δ ppm: 0.67 (s, 3H, Me-18), 0.80 (t, J¼7.24
Hz, 3H, Me-29), 0.83 (d, J¼7.04Hz, 3H, Me-27), 0.91 (d, J¼6.44Hz, 3H, Me-26), 0.98 (s, 3H, Me-19), 1.02 (d, J¼6.64Hz, 3H, Me-21),
2.00 (s, 3H, CH3CO-3´), 2.02 (s, 3H, CH3CO-2´), 2.05 (s, 3H, CH3CO-4´), 2.08 (s, 3H, CH3CO-6´), 3.48 (m, 1H, H-3), 3.67 (m, 1H, H-2´), 4.1
(dd, J¼12.2, 2.88Hz, 1H, H-6´a), 4.26 (dd, J¼12.22, 4.82Hz, 1H, H-6´b), 4.59 (d, J¼8.0Hz, 1H, H-1´), 4.96 (t, J¼ 9.48Hz, 1H, H-3´), 5.03
(dd, J¼ 14.16, 5.56Hz, 1H, H-23), 5.07 (t, J¼ 9.68Hz, 1H, H-5´), 5.13 (dd, J¼15.16, 6.52Hz, 1H, H-22), 5.20 (t, J¼9.52Hz, 1H, H-4´) 5.36
(da, J¼4.84Hz, 1H, H-6).
Fig. 8. Stigmasta-5,22-dien-3β-O-D-glucopyranoside. NMR 13C (100MHz, DMSO-d6): δ (ppm): 11.69 (C29), 11.80 (C18), 18.63 (C21),
18.85 (C27), 18.95 (C19), 19.12 (C26), 22.62 (C11), 23.88 (C28), 24.88 (C15), 29.26 (C16), 31.38 (C7, C8), 31.43 (C24, C25), 33.35 (C2), 35.49
(C20), 36.23 (C10), 36.83 (C4), 38.30 (C1), 39 (C12), 41.87 (C13), 49.61 (C9), 55.43 (C17), 56.27 (C14), 61.11 (C6´), 70.12 (C2´), 73.48 (C4´),
76.76 (C5´), 76.92 (C3´), 76.98 (C3), 100.78 (C1´), 121.24 (C6), 130.74 (C23), 138.06 (C22), 140.47 (C5).
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Fig. 10. Stigmasta-5,22-dien-3β-O-D-tetraacetylglucopyranoside. NMR 13C (100MHz, CDCl3) δ ppm: 11.89(C29), 12.02
(C18),18.81 (C21),19.07(C27), 19.39 (C19), 19.85 (C26), 20.65 (CH3CO-6´), 20.68 (CH3CO-4´), 20.76 (CH3CO-3´), 20.80 (CH3CO-2´),
21.08 (C11), 23.10 (C28), 24.33 (C15), 28.27 (C16), 29.48 (C24), 31.90 (C8, C25), 31.98 (C7), 33.98 (C-2), 36.16 (C20), 36.76 (C10),
37.23 (C1), 38.95 (C4), 39.77 (C12), 42.36 ( C13), 50.20 (C9), 56.09 (C17), 56.79 (C14), 62.15 (C6´), 68.53 (C4´), 71.54 (C3´), 71.73
(C5´), 72.96 (C3), 80.12 (C2´), 99.68 (C1´), 122.20 (C6), 129.34 (C23), 138.32 (C22), 140.40 (C5), 169.34 (CH3CO-3´), 169.44
(CH3CO-4´), 170.40 (CH3CO-2´), 170.74 (CH3CO-6´).
Fig. 11. Methyl gallate, NMR 1H (400MHz, Acetone-d6) δ ppm: 3.78 (s, 3H, OMe), 7.11 (s, 2H, H-2, H-6), 8.17 (s, 3H, OH).
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Fig. 12. Methyl gallate, NMR 13C (100MHz, Acetone-d6) δ ppm: 51.01 (OMe), 108.92 (C2, C6), 120.93 (C1), 137.82 (C4), 145.16
(C3, C5), 166.27 (COOR).
Fig. 13. Methyl 3,4,5-triacetyloxybenzoate, NMR 1H (400MHz, CDCl3) δ ppm: 2.32 (s, 9H, 3x CH3CO), 3.92 (s, 3H, OMe), 7.82
(s, H-2, H 6).
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Fig. 14. Methyl 3,4,5-triacetyloxybenzoate, NMR 13C (100MHz, CDCl3) δ ppm: 20.17 (CH3CO-4), 20.58 (CH3CO-3, CH3CO-5),
52.57 (OCH3), 122.22 (C2, C6), 128.29 (C1), 138.58 (C4), 143.39 (C3, C5), 164.90 (CH3CO-1), 166.44 (CH3CO-4), 167.61 (CH3CO-3,
CH3CO-5).
Fig. 15. Gallic acid, NMR 1H (400MHz, Acetone-d6) δ ppm: 3.08 (sa, 4H, OH-4), 7.14 (s, 2H, H-2, H-6), 8.22 (sa, 2H, OH-3, OH-5).
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Fig. 16. Gallic acid, NMR 13C (100MHz, Acetone-d6) δ ppm: 109.22 (C2, C6), 121.15 (C1), 137.77 (C4), 145.11 (C3, C5), 166.82
(COOH).
Fig. 17. (2S) -Naringenin 7-O-β-D-glucopyranoside, NMR 1H (400MHz, DMSO-d6) δ ppm: 2.73 (dd, J¼ 17.1, 2.62Hz, 1H, H-3β), 3.14
(m, 1H, H-3α), 3.22 (m, 2H, H-4´´, H-2´´), 3.37 (m, 2H, H-3´ ,´ H-5´´), 3.42 (dd, J¼ 11.68, 5.64Hz, 1H, H-6a´´), 3.65 (dd, J¼ 11.04, 4.68
Hz, 1H, H-6b´´), 4.54 (t, J¼ 5.56, 1H, OH-6”), 4.95 (d, J¼ 7.4Hz, 1H, H-1´´), 5.01 (d, J¼ 5.2Hz, 1H, OH-4´´), 5.08 (d, J¼ 4.72Hz, 1H,
OH-3´´), 5.33 (d, J¼ 4.88Hz, 1H, OH-2´´), 5.50 (dd, J¼ 12.6, 2.48Hz, 1H, H-2), 6.13 (d, J¼ 2.2, 1H, H-6), 6.15 (d, J¼ 1.96, 1H, H-8), 6.79
(d, J¼ 8.4Hz, 2H, H-3´, H-5´), 7.32 (d, J¼ 8.44Hz, 2H, H-2´, H-6´), 9.59 (s, 1H, OH-4´), 12.05 (s, 1H, OH-5).
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Fig. 18. (2S) -Naringenin 7-O-β-D-glucopyranoside. NMR 13C (100MHz, DMSO-d6) δ ppm: 42.55 (C3), 61.05 (C6´´), 69.98 (C4´´),
73.50 (C2´´), 76.80 (C3´´), 77.56 (C5´´), 79.13 (C2), 95.92 (C8), 96.97 (C6), 100.10 (C1´´), 103.73 (C10), 115.65 (C3´, C5´), 128.89 (C2´,
C6´), 129.11 (C1´), 158.28 (C4´), 163.25 (C5), 163.41 (C9), 165.79 (C7), 197. 67 (C4).
Fig. 19. Pinitol, NMR 1H (400MHz, D2O) δ (ppm): 3.18 (t, J¼9.64Hz, 1H, H-6), 3.44 (s, 3H, OCH3), 3.49 (t, J¼9.64Hz, 1H, H-1), 3.55
(dd, J¼9.94, 2.38Hz, 1H, H-2), 3.65 (dd, J¼9.98, 2.42Hz, 1H, H-5), 3.84 (m, 2H, H-3, H-4).
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Fig. 20. Pinitol. NMR 13C (100MHz, D2O) δ (ppm): 59.67 (OCH3), 69.76 (C5), 70.47 (C2), 71.40 (C3), 71.61 (C4), 72.07 (C1),
82.72 (C6).
Fig. 21. Sucrose, NMR 1H (400MHz, D2O) δ (ppm): 3.43 (t, J¼9.42Hz, 1H, H-4), 3.52 (dd, J¼10, 3.84Hz, 1H, H-2), 3.63 (s, 2H, H-1´),
3.72 (t, J¼9.56Hz, 1H, H-3), 3.78 (d, J¼2.96Hz, 2H, H-6), 3.79 (d, J¼2.8Hz, 2H, H-6´), 3.83 (m, 1H, H-5), 3.86 (m, 1H, H-5´), 4.01
(t, J¼ 8.56Hz, 1H, H-4´), 4.18 (d, J¼8.76Hz, 1H, H-3´), 5.38 (d, J¼3.88Hz, 1H, H-1).
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Fig. 22. Sucrose. NMR 13C (100MHz, D2O) δ (ppm): 62.59 (C6), 63.82 (C1´), 64.84 (C6´), 71.70 (C4), 73.55 (C2), 74.88 (C5), 75.05
(C3), 76.47 (C4´), 78.88 (C3´), 83.85 (C5´), 94.66 (C1), 106.17 (C2´).
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